logo
logo
Balchem Corporation

Balchem Corporation

NASDAQ•BCPC
CEO: Mr. Theodore L. Harris
セクター: Basic Materials
業種: Chemicals - Specialty
上場日: 1986-06-03
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment also offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production, and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.
連絡先情報
5 Paragon Drive, Montvale, NJ, 07645, United States
845-326-5600
www.balchem.com
時価総額
$5.81B
PER (TTM)
39.3
33.5
配当利回り
0.5%
52週高値
$183.01
52週安値
$139.17
52週レンジ
92%
順位21Top 7.6%
6.0
F-Score
改良版 Piotroski 分析
10年ファンダメンタル
強い • 6 / 9 ポイント
スコアレンジ (0-9)
8-9: 価値が優れている
6-7: 基礎体質が強い
4-5: 全体的に堅調
0-3: パフォーマンスが弱い
データ期間: 2016-2025

財務ダッシュボード

Q3 2025 データ

売上高

$267.56M+11.51%
直近4四半期の推移

EPS

$1.25+20.19%
直近4四半期の推移

フリーCF

$50.67M+20.20%
直近4四半期の推移

2025 Q3 決算ハイライト

主なハイライト

Net Sales Growth Strong Nine months net sales reached $773.544M, growing 8.4%. HNH segment sales grew 8.9% driven by volume and pricing.
Net Earnings Jump 21.8% Nine months net earnings totaled $115.620M, marking a substantial 21.8% increase year-over-year comparison. Operating margin improved to 20.3%.
Operating Cash Flow Rises Cash provided by operating activities was $149.281M for nine months, increasing 15.1%. Investing activities used $27.475M.
Interest Expense Significantly Lower Nine months net interest expense decreased 39.3% to $8.319M due to lower outstanding borrowings under the 2022 Credit Agreement.

リスク要因

Raw Material Input Costs Gross margin improvement partially offset by certain higher manufacturing input costs across nine months results comparison.
Foreign Currency Exchange Risk Exposure exists due to foreign subsidiaries' operations; currency fluctuations impact reported financial condition and results translation.
EU Anti-Dumping Duties Pending Provisional duties imposed on choline chloride imports from China; final measures expected by year-end 2025 impacting operations.
Litigation and Contingencies Exposure Ongoing involvement in various lawsuits, including Superfund site remediation liabilities at the Verona, Missouri facility.

見通し

Focus on Productivity Enhancements Management plans to leverage existing technology capabilities to optimize productivity and performance, driving efficiencies moving forward.
Active Acquisition Candidate Pursuit Company actively pursuing additional acquisition candidates; may seek additional bank loans or access financial markets if needed.
Capital Structure Management Repurchase program remains active; intends to acquire shares based on cash flow assessment and market conditions.
New Accounting Standard Adoption Evaluating impact of recently issued ASU 2024-03 regarding comprehensive income expense disaggregation disclosures.

同業比較

売上高 (TTM)

Sasol LimitedSSL
$28.48B
-6.5%
Celanese CorporationCE
$9.54B
-7.2%
Axalta Coating Systems Ltd.AXTA
$5.12B
-3.0%

粗利益率 (最新四半期)

Perimeter Solutions, Inc.PRM
58.3%
-4.5pp
Eldorado Gold CorporationEGO
43.3%
-13.1pp
Element Solutions IncESI
40.9%
+0.7pp

主要指標

銘柄コード
時価総額
PER (TTM)
ROE (TTM)
負債比率
EGO$9.15B24.89.2%19.6%
ESI$7.82B41.07.3%31.9%
AXTA$7.46B19.716.9%44.6%

長期トレンド

直近4四半期
売上高
純利益
営業キャッシュフロー
4四半期売上高CAGR
3.7%
緩やかな成長
4四半期純利益CAGR
6.3%
収益性の着実な向上
キャッシュフロー安定性
100%
優れたキャッシュフローの実績

深度リサーチ

次回決算:2026年2月20日
|
EPS:$1.29
|
売上高:$259.59M
財務レポート
財務データ
ニュース
全年度
  • Form 10-Q - Q3 2025

    会計期末: 2025年9月30日|提出日: 2025年10月21日|
    売上高: $267.56M+11.5%
    |
    EPS: $1.25+20.2%
    予想を上回る
  • Form 10-Q - Q2 2025

    会計期末: 2025年6月30日|提出日: 2025年7月31日|
    売上高: $255.47M+9.1%
    |
    EPS: $1.18+19.2%
    予想を上回る
  • Form 10-Q - Q1 2025

    会計期末: 2025年3月31日|提出日: 2025年4月24日|
    売上高: $250.52M+4.5%
    |
    EPS: $1.14+26.7%
    予想を上回る
  • Form 10-K - FY 2024

    会計期末: 2024年12月31日|提出日: 2025年2月21日|
    売上高: $953.68M+3.4%
    |
    EPS: $3.97+17.5%
    予想を上回る
  • Form 10-Q - Q3 2024

    会計期末: 2024年9月30日|提出日: 2024年10月25日|
    売上高: $239.94M+4.3%
    |
    EPS: $1.04+14.3%
    予想を下回る
  • Form 10-Q - Q2 2024

    会計期末: 2024年6月30日|提出日: 2024年7月26日|
    売上高: $234.08M+1.2%
    |
    EPS: $0.99+5.3%
    予想を下回る
  • Form 10-Q - Q1 2024

    会計期末: 2024年3月31日|提出日: 2024年5月3日|
    売上高: $239.66M+3.1%
    |
    EPS: $0.90+26.8%
    予想を下回る
  • Form 10-K - FY 2023

    会計期末: 2023年12月31日|提出日: 2024年2月16日|
    売上高: $922.44M-2.1%
    |
    EPS: $3.38+2.7%
    予想を上回る